TITLE

Adult Stem Cells--Real Hope for the Future, Real Help for Patients Now

AUTHOR(S)
Prentice, David A.
PUB. DATE
January 2011
SOURCE
National Right to Life News;Jan2011, Vol. 38 Issue 1, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article looks forward to the future of research on embryonic stem cell. It criticizes embryonic stem cell research for not helping a single patient. It also offers an overview of three experimental trials approved in the U.S. that propose to utilize derivatives of embryonic stem cells to treat spinal cord injury or blindness. The use of adult stem cells in the treatment of multiple sclerosis is also suggested.
ACCESSION #
57671465

 

Related Articles

  • Stem Cell Tourism. Cook, Michael // Australasian Science;Oct2011, Vol. 32 Issue 8, p48 

    The article discusses the issue whether stem cells can be used as a therapy for diabetes and hair loss. It notes the cases in which bovine cells or unsorted tissue slurries from human fetal brain are given by unscrupulous clinics to patients. It clarifies that scientists badly sold stem cells to...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Pacific Edition);11/8/2004 (Pacific Edition), Vol. 144 Issue 19, p46 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Atlantic Edition);11/8/2004 (Atlantic Edition), Vol. 144 Issue 19, p54 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Consent to the use of aborted fetuses in stem cell research and therapies. Pfeffer, N.; Kent, J. // Clinical Ethics;2006, Vol. 1 Issue 4, p216 

    This paper identifies the legal and policy framework relating to the use of aborted fetuses in stem cell research and therapies and contrasts this with the collection of embryos for research. It suggests that more attention should be given to questions about the kind of consent sought by...

  • Direct Reprogramming. Marb├ín, Eduardo; Cingolani, Eugenio // JAMA: Journal of the American Medical Association;7/7/2015, Vol. 314 Issue 1, p19 

    The authors comment on the direct reprogramming of stem cells for therapeutics. Topics covered include concerns that have restricted in vivo applications of tissues and organs to be recreated from embryonic stem cells, the limitations of induced stem cells as well as the complexity of...

  • Clinic Roundup.  // BioWorld Today;4/24/2013, Vol. 24 Issue 78, p3 

    This section offers news briefs on the biotechnology industry in the U.S. Acorda Therapeutics Inc. has started enrollment for its first trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis. The first subject of Advanced Cell Technology Inc. for its...

  • THE STEM-CELL SAGA.  // Popular Science;Mar2012, Vol. 280 Issue 3, p88 

    The article discusses the history of embryonic stem cell research, examining objections to stem-cell research by anti-abortion activists as well as the approval of a clinical trial of stem-cell therapy by the U.S. Food and Drug Administration.

  • BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on the initiation of a preclinical study by BrainStorm Cell Therapeutics Inc. for evaluating efficacy of NurOwn stem cell technology in treatment of Multiple Sclerosis. Positive proof of concept results has been obtained by the company for the stem cell technology...

  • News In brief.  // Nature Medicine;Aug2006, Vol. 12 Issue 8, p868 

    The article presents brief news items related to medical research during the months of June and July 2006. These include the European Union's approval of funding for human embryonic stem cell research, a test developed by British researchers that can screen embryos for nearly 6,000 inherited...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics